Skip to main content
. Author manuscript; available in PMC: 2012 Jul 3.
Published in final edited form as: Drug Discov Today Ther Strateg. 2011 Winter;8(3-4):77–83. doi: 10.1016/j.ddstr.2011.06.006

Table 1.

Disease areas most relevant to respondents’ researcha

Category All respondents
(n=696)
Number Percentb
Nervous system diseases [CIO] 236 34%
Neoplasms [C04] 181 26%
Cardiovascular diseases [C14] 171 25%
Immune system diseases [C20] 166 24%
Nutritional and metabolic diseases [C18] 127 18%
Bacterial infections and mycoses [C01] 112 16%
Endocrine system diseases [C19] 110 16%
Respiratory tract diseases [C08] 103 15%
Viral diseases [C02]   98 14%
Musculoskeletal diseases [C05]   98 14%
Digestive system diseases [C06]   94 14%
Hemic and lymphatic diseases [C15]   72 10%
Congenital, hereditary, and neonatal diseases and abnormalities [C16] 72 10%
Skin and connective tissue diseases [C17]   71 10%
Eye diseases [C11]   48   7%
Female urogenital diseases and pregnancy complications [C13] 52   7%
Male urogenital diseases [C12]   45   6%
Parasitic diseases [C03]   43   6%
Otorhinolaryngologic diseases [C09]   23   3%
Stomatognathic diseases [C07]   13   2%
a

Survey respondents were asked to ‘Please check all general disease MeSH Headings that are relevant to your research research’ to categorize their research interests using MeSH headings to facilitate future connections with the Foci Foci-of-Expertise (FoX) Synergy Brower.

b

The majority (62.8%) of investigators listed multiple interest areas. The total percentages will not add up to 100%.